News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Charles H. Weaver, MD
April 4, 2017
Keytruda Shows Promise in Treatment of Mesothelioma
Charles H. Weaver, MD
March 20, 2017
Mexican Women Develop Breast Cancer Earlier Than Other Populations
Charles H. Weaver, MD
March 15, 2017
Dignity Therapy and Cancer
Charles H. Weaver, MD
March 14, 2017
Initial High-Dose Chemotherapy Improves Survival in Aggressive NHL
Charles H. Weaver, MD
March 9, 2017
Anal Cancer on the Rise in Men with HIV
Charles H. Weaver, MD
February 28, 2017
Sunitinib Promising for Metastatic Renal Cell Carcinoma
Charles H. Weaver, MD
February 23, 2017
Unique Gene Signature Predicts Potentially Lethal Prostate Cancers
Charles H. Weaver, MD
February 16, 2017
Celebrex® Effective in Reversing Precancerous Cervical Changes
Charles H. Weaver, MD
February 7, 2017
Imbruvica® is approved by FDA for Marginal Zone Lymphoma
Charles H. Weaver, MD
January 24, 2017
Many Late Stage Lung Cancer Patients do not Receive Treatment
Charles H. Weaver, MD
January 3, 2017
Keytruda® Treatment of Mesothelioma
Charles H. Weaver, MD
December 20, 2016
Anti-Inflammatory Drug Combination Appears to Improve Blood Counts for Persons
Charles H. Weaver, MD
Previous Page
1
…
261
262
263
264
265
…
381
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website